Poland· PL-100205957
Hotlec
A other topical products for joint and muscular pain product containing methylis salicylas + camphora + pini aetheroleum + terebinthini aetheroleum, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Methylis salicylas + camphora + pini aetheroleum + terebinthini aetheroleum is registered in 5 of 19 countries.
Countries holding a registration under ATC M02AX (other topical products for joint and muscular pain), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Methylis salicylas + camphora + pini aetheroleum + terebinthini aetheroleum · ATC M02AX
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Methylis salicylas + Camphora + Pini aetheroleum + Terebinthini aetheroleum
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- M02AX
- ATC class
- Other topical products for joint and muscular pain
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990270217
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under M02AX
Other topical products for joint and muscular pain, as other registers publish it.
- NorwayDolobene ratiopharmTeva B.V.
- FinlandFinalgonBoehringer Ingelheim International GmbH
- BelgiumFlexagile Creme 35 mg/100 mgP&G Health Belgium
- PolandReparil Gel NDelfarma Sp. z o.o.
- CzechiaREPARIL NMylan IRE Healthcare Limited, Dublin
- CzechiaREPARIL NMylan IRE Healthcare Limited, Dublin
- CzechiaREPARIL NMylan IRE Healthcare Limited, Dublin
- CzechiaREPARIL NMylan IRE Healthcare Limited, Dublin
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d765d6b7-1f73-4d11-9337-be5f3286ade8 GET /v1/drugs/d765d6b7-1f73-4d11-9337-be5f3286ade8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(100 mg + 10 mg + 5 mg + 5 mg)/g",
"packaging": "05909990270217 ¦ OTC ¦ 58195\n1 tuba 30 g",
"substance": "Methylis salicylas 100 mg + Camphorum 10 mg + Pini sylvestris aetheroleum 5 mg + Terebinthini aetheroleum ab pinum pinastrum 5 mg",
"common_name": "Methylis salicylas + Camphora + Pini aetheroleum + Terebinthini aetheroleum",
"pl_product_id": "100205957",
"pozwolenie_nr": "02702",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about methylis salicylas + camphora + pini aetheroleum + terebinthini aetheroleum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.